Evaluating the efficacy of sequential biologic therapies for rheumatoid arthritis patients with an inadequate response to tumor necrosis factor-α inhibitors

@inproceedings{RendasBaum2011EvaluatingTE,
  title={Evaluating the efficacy of sequential biologic therapies for rheumatoid arthritis patients with an inadequate response to tumor necrosis factor-α inhibitors},
  author={Regina Rendas-Baum and Gene Wallenstein and Tamas Koncz and Mark R Kosinski and Min Yang and John Bradley and Samuel H. Zwillich},
  booktitle={Arthritis research & therapy},
  year={2011}
}
INTRODUCTION The long-term treatment of rheumatoid arthritis (RA) most often involves a sequence of different therapies. The response to therapy, disease progression and detailed knowledge of the role of different therapies along treatment pathways are key aspects to help physicians identify the best treatment strategy. Thus, understanding the effectiveness of different therapeutic sequences is of particular importance in the evaluation of long-term RA treatment strategies. The objective of… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 19 extracted citations

Paeoniflorin Antagonizes TNF-α-Induced L929 Fibroblastoma Cells Apoptosis by Inhibiting NF-κBp65 Activation

Dose-response : a publication of International Hormesis Society • 2018
View 5 Excerpts
Highly Influenced

References

Publications referenced by this paper.
Showing 1-10 of 73 references

Abatacept for rheumatoid arthritis refractory to tumor necrosis factor alpha inhibition.

The New England journal of medicine • 2005
View 19 Excerpts
Highly Influenced

Effectiveness and safety of etanercept in subjects with RA who have failed infliximab therapy: 16-week, open-label, observational study

CO IIIBingham, A Ince, +3 authors S Baumgartner
Curr Med Res • 2009
View 8 Excerpts
Highly Influenced

Similar Papers

Loading similar papers…